Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy [4]

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 188-189

  Stoves, John ^a   Richardson, Donald ^a   Patel, Hitan ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BILIRUBIN; CALCIUM; CISPLATIN; CREATININE; DACARBAZINE; HEMOGLOBIN; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM; URATE;

ADULT; ASCITES; CANCER RECURRENCE; CASE REPORT; CENTRAL VENOUS PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DUODENUM BIOPSY; EDEMA; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HYPERURICEMIA; IMMUNOTHERAPY; KIDNEY DISEASE; LETTER; LIVER DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; MELANOMA; METASTASIS; OLIGURIA; PRIORITY JOURNAL;

EID: 0035164882     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.188     Document Type: Letter

References (7)

1. Metabolic emergencies
2. Tumor lysis syndrome
3. Uric acid and the kidney
4. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature
5. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazin, interferon alpha and interleukin-2 for patients with metastatic melanoma
6. Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma
7. Oncology and the kidney